In June, Syapse—a company that works with health systems to implement precision medicine across its organizations—took the next step in leading the shift toward precision medicine by launching the Syapse Precision Medicine Council.
In June, Syapse—a company that works with health systems to implement precision medicine across its organizations—took the next step in leading the shift toward precision medicine by launching the Syapse Precision Medicine Council. The council consists of oncology, operations, and research leaders from health systems dedicated to advancing precision medicine through sharing strategies and insights in order to identify best practices.
Dennis Shin, chief commercial officer of Syapse, discussed the formation of the council, how it plans to disrupt the current precision oncology landscape, and what he sees for the future of the council.
To listen, login to the website.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss?rel=0"
TuneIn: http://bit.ly/2gv7iwj?rel=0"
Stitcher: http://bit.ly/2gCqtFg?rel=0"
Syapse, Roche Team Up to Advance Precision Medicine in Oncology
Syapse Looks to Expand Precision Medicine Partnerships With New CEO
Oncologists Are Crucial to Advancing Precision Medicine
Precision Health AI Launches Platform to Deliver Data-Driven Insights in Oncology
Using Health IT to Increase Medication Adherence and Enhance Precision Medicine
Read more about Syapse and precision oncology:
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More